Literature DB >> 7334455

Experimental atherosclerosis in rats fed a vitamin D, cholesterol-rich diet.

M Kunitomo, K Kinoshita, Y Bandô.   

Abstract

Atherosclerotic lesions of the aorta and coronary arteries were induced in rats fed a diet supplemented with cholesterol and vitamin D2 for 8 weeks. Rats fed a purified diet supplemented with 1% cholesterol and 1.25 million units of vitamin D2/kg of diet showed cholesterol deposition in the aorta but no abnormal findings were observed either macroscopically or microscopically in the aorta and coronary arteries. Rats fed a diet supplemented with 1.5% cholesterol and 1.8 million units of vitamin D2/kg of diet showed no only marked deposition of cholesterol and calcium but also extensive macroscopic lesions of atherosclerosis in the aorta and coronary arteries. No significant deposition of cholesterol and calcium in the aorta of rats fed the diet without the vitamin D2 supplement was observed in either experiment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7334455     DOI: 10.1248/bpb1978.4.718

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  11 in total

1.  Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004.

Authors:  Michal L Melamed; Paul Muntner; Erin D Michos; Jaime Uribarri; Collin Weber; Jyotirmay Sharma; Paolo Raggi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-04-16       Impact factor: 8.311

Review 2.  Vitamin D therapy in chronic kidney disease and end stage renal disease.

Authors:  Michal L Melamed; Ravi I Thadhani
Journal:  Clin J Am Soc Nephrol       Date:  2011-12-22       Impact factor: 8.237

Review 3.  Vitamin D and cardiovascular disease and cancer: not too much and not too little? The need for clinical trials.

Authors:  Michal L Melamed; JoAnn E Manson
Journal:  Womens Health (Lond)       Date:  2011-07

4.  Serum 25-hydroxyvitamin d levels are not associated with subclinical vascular disease or C-reactive protein in the old order amish.

Authors:  Erin D Michos; Elizabeth A Streeten; Kathleen A Ryan; Evadnie Rampersaud; Patricia A Peyser; Lawrence F Bielak; Alan R Shuldiner; Braxton D Mitchell; Wendy Post
Journal:  Calcif Tissue Int       Date:  2009-01-16       Impact factor: 4.333

Review 5.  Potential for vitamin D receptor agonists in the treatment of cardiovascular disease.

Authors:  J R Wu-Wong
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

Review 6.  Modulation of vitamin D signaling is a potential therapeutic target to lower cardiovascular risk in chronic kidney disease.

Authors:  Peng Hu; Bo Hu; Jing Wang; Ling Lu; Yuan Han Qin
Journal:  Med Sci Monit       Date:  2011-06

Review 7.  Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease.

Authors:  Peng Hu; Qiang Xuan; Bo Hu; Ling Lu; Jing Wang; Yuan Han Qin
Journal:  Int J Biol Sci       Date:  2012-05-05       Impact factor: 6.580

8.  Stem cell therapy targets the neointimal smooth muscle cells in experimentally induced atherosclerosis: involvement of intracellular adhesion molecule (ICAM) and vascular cell adhesion molecule (VCAM).

Authors:  R M Hashem; L A Rashed; R M Abdelkader; K S Hashem
Journal:  Braz J Med Biol Res       Date:  2021-05-24       Impact factor: 2.590

Review 9.  Vitamin D in inflammatory diseases.

Authors:  Thea K Wöbke; Bernd L Sorg; Dieter Steinhilber
Journal:  Front Physiol       Date:  2014-07-02       Impact factor: 4.566

10.  Possible Therapeutic Effect of Stem Cell in Atherosclerosis in Albino Rats. A Histological and Immunohistochemical Study.

Authors:  Samraa H Abdel-Kawi; Khalid S Hashem
Journal:  Int J Stem Cells       Date:  2015-11       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.